Inflammasome Therapeutics, Inc. — Form D

Inflammasome Therapeutics, Inc. of NEWTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-04. The offering totals $13.2M, of which $13.2M was reported sold. Industry: Biotechnology.

Offering

Filed: 2026-05-04
Form: D
Accession: 0001989925-26-000003
Industry: Biotechnology
Exemptions: 06b
Total offering: $13.2M
Amount sold: $13.2M
Investors: 62
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-582798

Issuer

Name: Inflammasome Therapeutics, Inc.
CIK: 0001989925
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 57 CHAPEL ST. STE. 100, NEWTON, MA, 02458
Phone: 6173311071

Officers, directors & promoters (12)

Name	Role	Location
Balamurali K. Ambati	Related Person	NEWTON, MA
Jayakrishna Ambati	Related Person	NEWTON, MA
Napoleone Ferrara	Related Person	NEWTON, MA
Babur B. Lateef	Related Person	NEWTON, MA
Chaniyilparampu N. Ramchand	Related Person	NEWTON, MA
Joon Lee	Director	LA JOLLA, CA
Balamurali Ambati	Director	Newton, MA
Napoleone Ferrara	Director	NEWTON, MA
Paul Ashton	Director	Newton, MA
Paul Ashton	Executive Officer	Newton, MA
Jayakrishna Ambati	Director	NEWTON, MA
Mary Weber	Director	Newton, MA

Other filings by this issuer (3)

Filed	Form	Offering	Sold
2025-03-17	D	$10.0M	$2.5M
2024-01-26	D/A	$3.8M	$3.8M
2023-08-14	D	$3.8M	$2.8M

More